Exodus Point Capital Management, LP Amicus Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

A detailed history of Exodus Point Capital Management, LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 817,007 shares of FOLD stock, worth $8.24 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
817,007
Previous 781,517 4.54%
Holding current value
$8.24 Million
Previous $7.75 Million 12.55%
% of portfolio
0.05%
Previous 0.05%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$9.55 - $12.09 $338,929 - $429,074
35,490 Added 4.54%
817,007 $8.73 Million
Q2 2024

Aug 13, 2024
BUY
$9.04 - $11.75 $1.25 Million - $1.62 Million
138,132 Added 21.47%
781,517 $7.75 Million
Q1 2024

May 14, 2024
SELL
$11.43 - $14.24 $3.41 Million - $4.24 Million
-298,048 Reduced 31.66%
643,385 $7.58 Million
Q3 2023

Nov 09, 2023
BUY
$11.78 - $13.86 $3.74 Million - $4.4 Million
317,580 Added 50.91%
941,433 $11.4 Million
Q2 2023

Aug 10, 2023
BUY
$10.72 - $13.3 $5.02 Million - $6.22 Million
468,018 Added 300.33%
623,853 $7.84 Million
Q1 2023

May 11, 2023
BUY
$10.91 - $13.54 $436,880 - $542,195
40,044 Added 34.58%
155,835 $1.73 Million
Q4 2022

Feb 13, 2023
SELL
$9.89 - $12.7 $1.75 Million - $2.25 Million
-177,189 Reduced 60.48%
115,791 $1.41 Million
Q3 2022

Nov 10, 2022
BUY
$9.82 - $12.75 $1.61 Million - $2.09 Million
163,746 Added 126.71%
292,980 $3.06 Million
Q2 2022

Aug 19, 2022
BUY
$6.23 - $11.12 $805,127 - $1.44 Million
129,234 New
129,234 $1.39 Million
Q1 2022

May 13, 2022
SELL
$7.89 - $12.48 $163,780 - $259,059
-20,758 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$9.82 - $12.44 $1.74 Million - $2.2 Million
-177,013 Reduced 89.5%
20,758 $240,000
Q3 2021

Nov 15, 2021
BUY
$8.74 - $11.84 $955,946 - $1.3 Million
109,376 Added 123.74%
197,771 $1.89 Million
Q2 2021

Aug 16, 2021
SELL
$8.71 - $10.72 $25,624 - $31,538
-2,942 Reduced 3.22%
88,395 $852,000
Q1 2021

May 17, 2021
BUY
$9.2 - $23.86 $93,352 - $242,107
10,147 Added 12.5%
91,337 $902,000
Q4 2020

Feb 16, 2021
SELL
$13.47 - $24.89 $341,141 - $630,364
-25,326 Reduced 23.78%
81,190 $1.88 Million
Q3 2020

Nov 16, 2020
BUY
$12.89 - $15.89 $1.37 Million - $1.69 Million
106,516 New
106,516 $1.5 Million
Q1 2020

May 15, 2020
SELL
$6.63 - $11.16 $308,009 - $518,460
-46,457 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$7.48 - $10.75 $177,702 - $255,387
23,757 Added 104.66%
46,457 $452,000
Q3 2019

Nov 14, 2019
BUY
$8.02 - $13.25 $182,054 - $300,775
22,700 New
22,700 $182,000

Others Institutions Holding FOLD

# of Institutions
312
Shares Held
314M
Call Options Held
630K
Put Options Held
669K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.83B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email